Evidence of intrathyroidal B-lymphocyte depletion after rituximab therapy in a patient with Graves' disease.
El Fassi
Daniel
D
Department of Endocrinology and Metabolism, Odense University Hospital, 5000 Odense C, Denmark.
Clemmensen
Ole
O
Nielsen
Claus H
CH
Silkiss
Rona Z
RZ
Hegedüs
Laszlo
L
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000187:drug effects*; D006111:Graves Disease / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008212:Lymphocyte Depletion / Q000379:methods; D000069283:Rituximab; D013961:Thyroid Gland / Q000276:immunology / Q000473:pathology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab